Literature DB >> 29283958

Risk of Pneumonia After Vertebral Compression Fracture in Women With Low Bone Density: A Population-Based Study.

Byunghyun Kim1, Joonghee Kim1, You Hwan Jo1, Si-Hyuck Kang2, Yeon Joo Lee3, Jae Hyuk Lee1, Je Eun Hwang1, Min Ji Park1, Sihyung Lee1.   

Abstract

STUDY
DESIGN: Retrospective large population-based study.
OBJECTIVE: The aim of this study is to elucidate the association between vertebral compression fractures (VCFs) and pneumonia. SUMMARY OF BACKGROUND DATA: VCF is known to be associated with impaired pulmonary function. However, the risk of developing pneumonia after new-onset VCF has not been evaluated.
METHODS: The data source was the National Health Screening Program Cohort, a population-based sample cohort of national health screening enrolees. Elderly women with low bone density identified during the life transition period health check-up were target population. Patients with newly diagnosed isolated VCF after the health check-up except those with cervical VCF were included as exposure group. Matched individuals still free of any type of VCF from the same population were included as control group with case/control ratio 3:1. The time to first occurrence of pneumonia were analyzed with Cox-regression analysis.
RESULTS: From the target population (N = 24,773), we matched 867 patients exposed to new-onset isolated VCFs with 2601 controls. In a multivariable Cox-regression analysis, isolated VCF was identified as an independent risk factor for development of a pneumonia (adjusted hazard ratio, 1.48; 95% confidence interval 1.14-1.91). Among the subtypes of VCF, thoracic/thoracolumbar VCF was independently associated with increased risk of pneumonia (adjusted hazard ratio, 2.13; 95% confidence interval 1.47-3.08).
CONCLUSION: Isolated VCF, especially those involving thoracic region, was associated with increased risk of pneumonia. LEVEL OF EVIDENCE: 4.

Entities:  

Mesh:

Year:  2018        PMID: 29283958     DOI: 10.1097/BRS.0000000000002536

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  6 in total

1.  Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors.

Authors:  Luigi di Filippo; Nicola Compagnone; Stefano Frara; Agnese Allora; Mauro Doga; Patrizia Rovere Querini; George Cremona; Andrea Giustina
Journal:  Endocrine       Date:  2022-06-08       Impact factor: 3.925

2.  Factors Impacting Mortality in Geriatric Patients with Acute Spine Fractures: A 12-Year Study of 613 Patients in Singapore.

Authors:  En Loong Soon; Adriel Zhijie Leong; Jean Chiew; Arun-Kumar Kaliya-Perumal; Chun Sing Yu; Jacob Yoong-Leong Oh
Journal:  Asian Spine J       Date:  2019-03-15

Review 3.  COVID-19 and the pituitary.

Authors:  Stefano Frara; Agnese Allora; Laura Castellino; Luigi di Filippo; Paola Loli; Andrea Giustina
Journal:  Pituitary       Date:  2021-05-03       Impact factor: 3.599

Review 4.  COVID-19 and hypopituitarism.

Authors:  Stefano Frara; Paola Loli; Agnese Allora; Chiara Santini; Luigi di Filippo; Pietro Mortini; Maria Fleseriu; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2021-08-13       Impact factor: 9.306

5.  SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters.

Authors:  Wei Qiao; Hui En Lau; Huizhi Xie; Vincent Kwok-Man Poon; Chris Chung-Sing Chan; Hin Chu; Shuofeng Yuan; Terrence Tsz-Tai Yuen; Kenn Ka-Heng Chik; Jessica Oi-Ling Tsang; Chris Chun-Yiu Chan; Jian-Piao Cai; Cuiting Luo; Kwok-Yung Yuen; Kenneth Man-Chee Cheung; Jasper Fuk-Woo Chan; Kelvin Wai-Kwok Yeung
Journal:  Nat Commun       Date:  2022-05-09       Impact factor: 17.694

6.  Risk of aortic dissection, congestive heart failure, pneumonia and acute respiratory distress syndrome in patients with clinical vertebral fracture: a nationwide population-based cohort study in Taiwan.

Authors:  Tse-Yen Yang; Ching-Yuan Lai; Feng-You Lee; Wei-Kung Chen; Cheng-Li Lin; Chia-Hung Kao
Journal:  BMJ Open       Date:  2019-11-21       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.